Abstract
The clinical importance of HBV-HIV co-infection comes from the fact that both viruses are highly transmissible and share similar routes of transmission. Co-infected individuals are more likely to develop liver cirrhosis and hepatocellular carcinoma. In view of the above, this manuscript is a quantitative, sectional, descriptive study with secondary data obtained from the analysis of medical records of 88 individuals with chronic hepatitis B. Thus, the purpose of this manuscript is to estimate the frequency of HBV-HIV co-infection and to identify the presence of liver damage. The results revealed an HBV-HIV co-infection rate of 9.1% (8//88), with two individuals being infected with the HIV-HBV-HCV virus concurrently. A large percentage of patients are male and heterosexual. There was a relationship between risky sexual behavior (sex without using a condom, multiple sexual partners) and the acquisition of hepatitis B and HIV. Related to the presence of liver lesions, it was observed that only one patient is diagnosed with liver cirrhosis, but there were no cases of hepatocellular carcinoma. Considering the increase in the quality of life and survival of people with HIV, the need to maintain protocols for the investigation of hepatocellular carcinoma is evident, thus seeking early detection and treatment.
Publisher
International Journal for Innovation Education and Research
Reference25 articles.
1. R. C. Alvariz, Hepatite crônica pelo vírus B (HBV). Revista Hospital Pedro Ernesto, v. 5, n. 1, pp. 16-34, jun. 2006.
2. I. Baudi, S. Lipima. N. Chin’ombe. S. Matapuri-zinyowera. S. Murakami. M. Isogawa. et al. Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe. Journal of Medical Virology, v. 89, n. 2, pp. 257-66. 2016.
3. A. Bertoletti. M. K. Maini. C. Ferrari. The host-pathogeninteractionduring HBV infection: immunological controversies. Antiviral Therapy. v. 15 n. 3, pp. 15-24, 2010.
4. Brasil. Ministério da Saúde (MS). Secretaria de Vigilância em Saúde. Departamento de DST, Aids e Hepatites Virais. Protocolo Clínico e Diretrizes Terapêuticas para hepatite B e Coinfecções. Brasília: MS; 2017.
5. D. Y. K. But. C. L. Lai. M. F. Yuen. Natural history of hepatitis-related hepatocellular carcinoma. World Journal of Gastroenterology, v. 14, n. 11, pp. 1652-56. 2008.